Clinical Trials on Gaucher Disease, Type 1 in United Kingdom
Total 27154 results
-
Amicus TherapeuticsCompletedGaucher Disease | Gaucher Disease, Type 1 | Type 1 Gaucher DiseaseUnited Kingdom, United States
-
Amicus TherapeuticsCompletedGaucher Disease | Gaucher Disease, Type 1 | Type 1 Gaucher DiseaseUnited Kingdom, Israel, South Africa, United States
-
Freeline TherapeuticsRecruitingGaucher Disease, Type 1Spain, Israel, United States, United Kingdom, Brazil, Germany, Paraguay
-
Genzyme, a Sanofi CompanyActive, not recruitingGaucher Disease Type 1 | Gaucher Disease Type 3Germany, United States, Japan, United Kingdom
-
Amicus TherapeuticsTerminatedType 1 Gaucher DiseaseUnited States, United Kingdom
-
SanofiActive, not recruitingGaucher's Disease Type III | Gaucher's Disease Type ICanada, Argentina, France, Italy, Japan, Russian Federation, Spain, Sweden, Turkey, United Kingdom
-
Amicus TherapeuticsCompletedGaucher Disease | Gaucher Disease, Type 1 | Type 1 Gaucher DiseaseUnited States
-
Cambridge University Hospitals NHS Foundation TrustMedical Research Council; National Institute for Health Research, United KingdomRecruitingGaucher Disease, Type III | Gaucher Disease, Type IUnited Kingdom
-
Baylor Research InstituteTexas Scottish Rite Hospital for ChildrenWithdrawnGaucher Disease Type 1 | Gaucher Disease Type 3United States
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
ShireCompletedGaucher Disease, Type 1Spain, Israel, United States, India, Paraguay, United Kingdom, Russian Federation, Tunisia, Argentina
-
ShireCompletedGaucher DiseaseUnited States, Spain, United Kingdom, Israel
-
ShireCompletedGaucher DiseaseUnited States, Israel, United Kingdom, Poland, Spain
-
Genzyme, a Sanofi CompanyCompletedGaucher Disease, Type 1United States, United Kingdom, Bulgaria, Canada, Colombia, India, Israel, Lebanon, Mexico, Russian Federation, Serbia, Tunisia
-
ActelionCompletedGaucher Disease Type 1United States, Taiwan, Canada, Spain, Australia, France, Brazil, Hungary, Czechia, Germany, Italy, Netherlands, United Kingdom
-
Imperial College LondonCompleted
-
Imperial College LondonOxford Brookes University; Institut d'Investigació Biomèdica de Girona Dr.... and other collaboratorsCompletedType1 Diabetes MellitusUnited Kingdom
-
University of BristolDiabetes UKCompleted
-
Imperial College LondonDexCom, Inc.UnknownType 1 Diabetes MellitusUnited Kingdom
-
Northampton General Hospital NHS TrustActive, not recruitingType 1 Diabetes MellitusUnited Kingdom
-
King's College LondonCompletedType 1 Diabetes Mellitus | LipohypertrophyUnited Kingdom
-
ShireCompletedGaucher Disease, Type 1United States, Israel, Argentina, India, Korea, Republic of, Paraguay, Poland, Russian Federation, Spain, Tunisia, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedGaucher Disease, Type 1United States, France, Germany, Italy, Brazil, Australia, Argentina, Canada, Egypt, Russian Federation, Spain, United Kingdom
-
University of CambridgeCambridge University Hospitals NHS Foundation Trust; Nottingham University... and other collaboratorsCompletedType 1 Diabetes MellitusUnited Kingdom
-
Queen's University, BelfastWithdrawn
-
Liverpool Hope UniversityCompleted
-
NHS LothianNHS Tayside; DexCom, Inc.RecruitingType 1 Diabetes MellitusUnited Kingdom
-
University of CambridgeDiabetes UKCompletedType 1 Diabetes MellitusUnited Kingdom
-
Royal Devon and Exeter NHS Foundation TrustUniversity of ExeterActive, not recruitingType 1 Diabetes | Type 1 Diabetes Mellitus Maturity OnsetUnited Kingdom
-
SanofiRecruitingGaucher's Disease Type IIIUnited States, Germany, Hungary, France, China, Japan, Canada, Argentina, Italy, Turkey
-
PfizerWithdrawnType 1 Gaucher DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedGaucher Disease, Type 1 | Cerebroside Lipidosis Syndrome | Glucocerebrosidase Deficiency Disease | Glucosylceramide Beta-Glucosidase Deficiency Disease | Gaucher Disease, Non-Neuronopathic FormUnited States, United Kingdom, Spain, Italy, Brazil, Canada, Poland
-
Genzyme, a Sanofi CompanyWithdrawnGaucher Disease, Type 1United States, India
-
King's College LondonKing's College Hospital NHS Trust; Juvenile Diabetes Research Foundation; Guy... and other collaboratorsCompletedHypoglycemia | Type 1 Diabetes MellitusUnited States, United Kingdom
-
Royal Devon and Exeter NHS Foundation TrustKing's College London; Leiden University Medical CenterCompletedType 1 Diabetes MellitusNetherlands, United Kingdom
-
Imperial College LondonCompletedType 1 Diabetes | Type 2 DiabetesUnited Kingdom
-
Northumbria UniversityNewcastle UniversityCompleted
-
Newcastle UniversitySanofi; Medtronic; Newcastle-upon-Tyne Hospitals NHS Trust; Newcastle Primary Care...Completed
-
University Research Foundation for Lysosomal Storage...University of PittsburghCompletedGaucher DiseaseUnited States
-
University of CambridgeMedical University of Graz; University Hospital Birmingham NHS Foundation Trust and other collaboratorsCompletedHypoglycemia | Type 1 Diabetes Mellitus | ArrythmiaUnited Kingdom
-
Prevail TherapeuticsEli Lilly and CompanyActive, not recruitingGaucher Disease, Type 2United States, United Kingdom
-
Prevail TherapeuticsEli Lilly and CompanyRecruitingGaucher Disease | Gaucher Disease, Type 1United States, Spain
-
Imperial College LondonNot yet recruiting
-
Imperial College LondonCompletedType 1 DiabetesUnited Kingdom
-
University of CambridgeCambridge University Hospitals NHS Foundation TrustCompletedType 1 DiabetesUnited Kingdom
-
Imperial College LondonCompletedType 1 DiabetesUnited Kingdom
-
University of ExeterKing's College London; Benaroya Research Institute; Royal Devon and Exeter NHS...RecruitingType1 Diabetes MellitusNetherlands, United States, United Kingdom
-
AVROBIOTerminatedType 1 Gaucher DiseaseUnited States, Canada
-
Imperial College LondonDexCom, Inc.RecruitingType 1 DiabetesUnited Kingdom
-
Cardiff UniversityCompletedType 1 DiabetesUnited Kingdom